nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—DDR2—Endochondral Ossification—SOX9—degenerative disc disease	0.0946	0.0946	CbGpPWpGaD
Regorafenib—DDR2—Endochondral Ossification—ADAMTS5—degenerative disc disease	0.0793	0.0793	CbGpPWpGaD
Regorafenib—DDR2—Endochondral Ossification—ADAMTS4—degenerative disc disease	0.0674	0.0674	CbGpPWpGaD
Regorafenib—DDR2—Endochondral Ossification—MMP13—degenerative disc disease	0.0426	0.0426	CbGpPWpGaD
Regorafenib—DDR2—Extracellular matrix organization—GDF5—degenerative disc disease	0.0319	0.0319	CbGpPWpGaD
Regorafenib—DDR2—Extracellular matrix organization—ADAMTS5—degenerative disc disease	0.0255	0.0255	CbGpPWpGaD
Regorafenib—DDR2—Extracellular matrix organization—ADAMTS3—degenerative disc disease	0.0255	0.0255	CbGpPWpGaD
Regorafenib—DDR2—Extracellular matrix organization—COL9A3—degenerative disc disease	0.0255	0.0255	CbGpPWpGaD
Regorafenib—DDR2—Extracellular matrix organization—ADAMTS4—degenerative disc disease	0.0217	0.0217	CbGpPWpGaD
Regorafenib—KIT—Differentiation Pathway—GDF5—degenerative disc disease	0.0206	0.0206	CbGpPWpGaD
Regorafenib—EPHX2—Metapathway biotransformation—CHST3—degenerative disc disease	0.0204	0.0204	CbGpPWpGaD
Regorafenib—DDR2—Extracellular matrix organization—COL9A2—degenerative disc disease	0.0199	0.0199	CbGpPWpGaD
Regorafenib—KDR—Integrin cell surface interactions—COL9A3—degenerative disc disease	0.0164	0.0164	CbGpPWpGaD
Regorafenib—FGFR1—Endochondral Ossification—SOX9—degenerative disc disease	0.0148	0.0148	CbGpPWpGaD
Regorafenib—RET—Posttranslational regulation of adherens junction stability and dissassembly—MMP3—degenerative disc disease	0.0143	0.0143	CbGpPWpGaD
Regorafenib—DDR2—Extracellular matrix organization—MMP13—degenerative disc disease	0.0137	0.0137	CbGpPWpGaD
Regorafenib—MAPK11—Parkinsons Disease Pathway—PARK2—degenerative disc disease	0.0133	0.0133	CbGpPWpGaD
Regorafenib—DDR2—Extracellular matrix organization—BMP2—degenerative disc disease	0.0133	0.0133	CbGpPWpGaD
Regorafenib—KDR—Integrin cell surface interactions—COL9A2—degenerative disc disease	0.0128	0.0128	CbGpPWpGaD
Regorafenib—FGFR1—Endochondral Ossification—ADAMTS5—degenerative disc disease	0.0124	0.0124	CbGpPWpGaD
Regorafenib—FGFR1—NCAM signaling for neurite out-growth—COL9A3—degenerative disc disease	0.0118	0.0118	CbGpPWpGaD
Regorafenib—FGFR2—Neural Crest Differentiation—SOX9—degenerative disc disease	0.011	0.011	CbGpPWpGaD
Regorafenib—FGFR1—Endochondral Ossification—ADAMTS4—degenerative disc disease	0.0105	0.0105	CbGpPWpGaD
Regorafenib—FGFR1—Neural Crest Differentiation—SOX9—degenerative disc disease	0.0103	0.0103	CbGpPWpGaD
Regorafenib—RAF1—NCAM signaling for neurite out-growth—COL9A3—degenerative disc disease	0.00946	0.00946	CbGpPWpGaD
Regorafenib—FGFR1—NCAM signaling for neurite out-growth—COL9A2—degenerative disc disease	0.00922	0.00922	CbGpPWpGaD
Regorafenib—DDR2—Extracellular matrix organization—MMP3—degenerative disc disease	0.00919	0.00919	CbGpPWpGaD
Regorafenib—PDGFRB—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP13—degenerative disc disease	0.0084	0.0084	CbGpPWpGaD
Regorafenib—RAF1—NCAM signaling for neurite out-growth—COL9A2—degenerative disc disease	0.00739	0.00739	CbGpPWpGaD
Regorafenib—KDR—Extracellular matrix organization—GDF5—degenerative disc disease	0.00679	0.00679	CbGpPWpGaD
Regorafenib—FGFR1—Endochondral Ossification—MMP13—degenerative disc disease	0.00667	0.00667	CbGpPWpGaD
Regorafenib—EPHA2—Axon guidance—COL9A3—degenerative disc disease	0.00654	0.00654	CbGpPWpGaD
Regorafenib—NTRK1—p75(NTR)-mediated signaling—MMP3—degenerative disc disease	0.00605	0.00605	CbGpPWpGaD
Regorafenib—UGT1A1—Metapathway biotransformation—CHST3—degenerative disc disease	0.00603	0.00603	CbGpPWpGaD
Regorafenib—UGT1A9—Metapathway biotransformation—CHST3—degenerative disc disease	0.00603	0.00603	CbGpPWpGaD
Regorafenib—FGFR2—Signaling by PDGF—COL9A3—degenerative disc disease	0.00577	0.00577	CbGpPWpGaD
Regorafenib—KIT—Signaling by PDGF—COL9A3—degenerative disc disease	0.00566	0.00566	CbGpPWpGaD
Regorafenib—PDGFRB—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP3—degenerative disc disease	0.00562	0.00562	CbGpPWpGaD
Regorafenib—KDR—Extracellular matrix organization—ADAMTS3—degenerative disc disease	0.00542	0.00542	CbGpPWpGaD
Regorafenib—KDR—Extracellular matrix organization—COL9A3—degenerative disc disease	0.00542	0.00542	CbGpPWpGaD
Regorafenib—KDR—Extracellular matrix organization—ADAMTS5—degenerative disc disease	0.00542	0.00542	CbGpPWpGaD
Regorafenib—FGFR1—Signaling by PDGF—COL9A3—degenerative disc disease	0.00538	0.00538	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling by PDGF—COL9A3—degenerative disc disease	0.00536	0.00536	CbGpPWpGaD
Regorafenib—RAF1—Oncostatin M Signaling Pathway—MMP13—degenerative disc disease	0.00528	0.00528	CbGpPWpGaD
Regorafenib—RAF1—AGE/RAGE pathway—MMP13—degenerative disc disease	0.00521	0.00521	CbGpPWpGaD
Regorafenib—EPHA2—Axon guidance—COL9A2—degenerative disc disease	0.0051	0.0051	CbGpPWpGaD
Regorafenib—BRAF—Senescence and Autophagy in Cancer—BMP2—degenerative disc disease	0.00502	0.00502	CbGpPWpGaD
Regorafenib—ABL1—Posttranslational regulation of adherens junction stability and dissassembly—MMP3—degenerative disc disease	0.00492	0.00492	CbGpPWpGaD
Regorafenib—NTRK1—BDNF signaling pathway—BMP2—degenerative disc disease	0.00484	0.00484	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by PDGF—COL9A3—degenerative disc disease	0.00483	0.00483	CbGpPWpGaD
Regorafenib—EPHA2—Developmental Biology—COL9A3—degenerative disc disease	0.00466	0.00466	CbGpPWpGaD
Regorafenib—KDR—Extracellular matrix organization—ADAMTS4—degenerative disc disease	0.00461	0.00461	CbGpPWpGaD
Regorafenib—MAPK11—Metabolism of mRNA—RPL34—degenerative disc disease	0.00461	0.00461	CbGpPWpGaD
Regorafenib—KDR—Axon guidance—COL9A3—degenerative disc disease	0.0046	0.0046	CbGpPWpGaD
Regorafenib—FGFR2—Signaling by PDGF—COL9A2—degenerative disc disease	0.0045	0.0045	CbGpPWpGaD
Regorafenib—KIT—Signaling by PDGF—COL9A2—degenerative disc disease	0.00442	0.00442	CbGpPWpGaD
Regorafenib—RAF1—Signaling by PDGF—COL9A3—degenerative disc disease	0.00431	0.00431	CbGpPWpGaD
Regorafenib—KDR—Extracellular matrix organization—COL9A2—degenerative disc disease	0.00423	0.00423	CbGpPWpGaD
Regorafenib—FGFR1—Signaling by PDGF—COL9A2—degenerative disc disease	0.0042	0.0042	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling by PDGF—COL9A2—degenerative disc disease	0.00419	0.00419	CbGpPWpGaD
Regorafenib—MAPK11—Metabolism of RNA—RPL34—degenerative disc disease	0.00394	0.00394	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by PDGF—COL9A2—degenerative disc disease	0.00377	0.00377	CbGpPWpGaD
Regorafenib—CYP2B6—Metapathway biotransformation—CHST3—degenerative disc disease	0.00375	0.00375	CbGpPWpGaD
Regorafenib—EPHA2—Developmental Biology—COL9A2—degenerative disc disease	0.00364	0.00364	CbGpPWpGaD
Regorafenib—KDR—Axon guidance—COL9A2—degenerative disc disease	0.00359	0.00359	CbGpPWpGaD
Regorafenib—RAF1—Oncostatin M Signaling Pathway—MMP3—degenerative disc disease	0.00353	0.00353	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—CHST3—degenerative disc disease	0.00353	0.00353	CbGpPWpGaD
Regorafenib—RAF1—Senescence and Autophagy in Cancer—BMP2—degenerative disc disease	0.00347	0.00347	CbGpPWpGaD
Regorafenib—FGFR1—Axon guidance—COL9A3—degenerative disc disease	0.00339	0.00339	CbGpPWpGaD
Regorafenib—RAF1—Signaling by PDGF—COL9A2—degenerative disc disease	0.00336	0.00336	CbGpPWpGaD
Regorafenib—KDR—Developmental Biology—COL9A3—degenerative disc disease	0.00329	0.00329	CbGpPWpGaD
Regorafenib—CYP2C8—Metapathway biotransformation—CHST3—degenerative disc disease	0.00317	0.00317	CbGpPWpGaD
Regorafenib—ABL1—Axon guidance—COL9A3—degenerative disc disease	0.00297	0.00297	CbGpPWpGaD
Regorafenib—KDR—Extracellular matrix organization—MMP13—degenerative disc disease	0.00292	0.00292	CbGpPWpGaD
Regorafenib—CYP2C19—Metapathway biotransformation—CHST3—degenerative disc disease	0.00283	0.00283	CbGpPWpGaD
Regorafenib—MAPK11—Developmental Biology—COL9A3—degenerative disc disease	0.00283	0.00283	CbGpPWpGaD
Regorafenib—KDR—Extracellular matrix organization—BMP2—degenerative disc disease	0.00282	0.00282	CbGpPWpGaD
Regorafenib—RAF1—Axon guidance—COL9A3—degenerative disc disease	0.00271	0.00271	CbGpPWpGaD
Regorafenib—RAF1—BDNF signaling pathway—BMP2—degenerative disc disease	0.0027	0.0027	CbGpPWpGaD
Regorafenib—FGFR1—Axon guidance—COL9A2—degenerative disc disease	0.00265	0.00265	CbGpPWpGaD
Regorafenib—CYP2C9—Metapathway biotransformation—CHST3—degenerative disc disease	0.00258	0.00258	CbGpPWpGaD
Regorafenib—KDR—Developmental Biology—COL9A2—degenerative disc disease	0.00257	0.00257	CbGpPWpGaD
Regorafenib—FGFR1—Developmental Biology—COL9A3—degenerative disc disease	0.00242	0.00242	CbGpPWpGaD
Regorafenib—ABL1—Axon guidance—COL9A2—degenerative disc disease	0.00232	0.00232	CbGpPWpGaD
Regorafenib—MAPK11—Developmental Biology—COL9A2—degenerative disc disease	0.00221	0.00221	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—COL9A3—degenerative disc disease	0.0022	0.0022	CbGpPWpGaD
Regorafenib—RAF1—Axon guidance—COL9A2—degenerative disc disease	0.00212	0.00212	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—COL9A3—degenerative disc disease	0.00212	0.00212	CbGpPWpGaD
Regorafenib—KDR—Extracellular matrix organization—MMP3—degenerative disc disease	0.00195	0.00195	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—COL9A3—degenerative disc disease	0.00194	0.00194	CbGpPWpGaD
Regorafenib—FGFR1—Developmental Biology—COL9A2—degenerative disc disease	0.00189	0.00189	CbGpPWpGaD
Regorafenib—BRAF—Disease—CHST3—degenerative disc disease	0.00175	0.00175	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—COL9A2—degenerative disc disease	0.00172	0.00172	CbGpPWpGaD
Regorafenib—CYP3A4—Metapathway biotransformation—CHST3—degenerative disc disease	0.0017	0.0017	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—COL9A2—degenerative disc disease	0.00165	0.00165	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—COL9A3—degenerative disc disease	0.00164	0.00164	CbGpPWpGaD
Regorafenib—FGFR2—Disease—CHST3—degenerative disc disease	0.00163	0.00163	CbGpPWpGaD
Regorafenib—KIT—Disease—CHST3—degenerative disc disease	0.0016	0.0016	CbGpPWpGaD
Regorafenib—FGFR1—Disease—CHST3—degenerative disc disease	0.00152	0.00152	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—COL9A2—degenerative disc disease	0.00151	0.00151	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—CHST3—degenerative disc disease	0.00151	0.00151	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—CHST3—degenerative disc disease	0.00136	0.00136	CbGpPWpGaD
Regorafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—degenerative disc disease	0.00136	0.00136	CbGpPWpGaD
Regorafenib—FGFR2—Adaptive Immune System—PARK2—degenerative disc disease	0.00133	0.00133	CbGpPWpGaD
Regorafenib—KIT—Adaptive Immune System—PARK2—degenerative disc disease	0.00131	0.00131	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—COL9A2—degenerative disc disease	0.00128	0.00128	CbGpPWpGaD
Regorafenib—FGFR1—Adaptive Immune System—PARK2—degenerative disc disease	0.00124	0.00124	CbGpPWpGaD
Regorafenib—PDGFRA—Adaptive Immune System—PARK2—degenerative disc disease	0.00124	0.00124	CbGpPWpGaD
Regorafenib—MAPK11—Gene Expression—RPL34—degenerative disc disease	0.00123	0.00123	CbGpPWpGaD
Regorafenib—RAF1—Disease—CHST3—degenerative disc disease	0.00121	0.00121	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—COL9A3—degenerative disc disease	0.00116	0.00116	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—BMP2—degenerative disc disease	0.00114	0.00114	CbGpPWpGaD
Regorafenib—BRAF—Disease—RPL34—degenerative disc disease	0.00113	0.00113	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—PARK2—degenerative disc disease	0.00112	0.00112	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—COL9A3—degenerative disc disease	0.00109	0.00109	CbGpPWpGaD
Regorafenib—FGFR2—Disease—RPL34—degenerative disc disease	0.00105	0.00105	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—CHST3—degenerative disc disease	0.00104	0.00104	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—CHST3—degenerative disc disease	0.00104	0.00104	CbGpPWpGaD
Regorafenib—KIT—Disease—RPL34—degenerative disc disease	0.00103	0.00103	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—PARK2—degenerative disc disease	0.000995	0.000995	CbGpPWpGaD
Regorafenib—FGFR1—Disease—RPL34—degenerative disc disease	0.000976	0.000976	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—RPL34—degenerative disc disease	0.000974	0.000974	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—COL9A3—degenerative disc disease	0.00094	0.00094	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—COL9A3—degenerative disc disease	0.000931	0.000931	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—COL9A2—degenerative disc disease	0.000903	0.000903	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—CHST3—degenerative disc disease	0.000887	0.000887	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—PARK2—degenerative disc disease	0.000881	0.000881	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—RPL34—degenerative disc disease	0.000877	0.000877	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—COL9A3—degenerative disc disease	0.000863	0.000863	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—COL9A2—degenerative disc disease	0.000853	0.000853	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—BMP2—degenerative disc disease	0.000853	0.000853	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—COL9A3—degenerative disc disease	0.000847	0.000847	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—PARK2—degenerative disc disease	0.000809	0.000809	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—COL9A3—degenerative disc disease	0.000804	0.000804	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—COL9A3—degenerative disc disease	0.000802	0.000802	CbGpPWpGaD
Regorafenib—KIT—Immune System—PARK2—degenerative disc disease	0.000794	0.000794	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—MMP3—degenerative disc disease	0.000793	0.000793	CbGpPWpGaD
Regorafenib—RAF1—Disease—RPL34—degenerative disc disease	0.000782	0.000782	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—PARK2—degenerative disc disease	0.000754	0.000754	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—PARK2—degenerative disc disease	0.000752	0.000752	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—COL9A2—degenerative disc disease	0.000734	0.000734	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—COL9A2—degenerative disc disease	0.000727	0.000727	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—COL9A3—degenerative disc disease	0.000723	0.000723	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—PARK2—degenerative disc disease	0.000677	0.000677	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—COL9A2—degenerative disc disease	0.000674	0.000674	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—COL9A2—degenerative disc disease	0.000662	0.000662	CbGpPWpGaD
Regorafenib—ABL1—Immune System—PARK2—degenerative disc disease	0.00066	0.00066	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—CHST3—degenerative disc disease	0.00065	0.00065	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—COL9A3—degenerative disc disease	0.000644	0.000644	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—COL9A2—degenerative disc disease	0.000628	0.000628	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—COL9A2—degenerative disc disease	0.000626	0.000626	CbGpPWpGaD
Regorafenib—RAF1—Immune System—PARK2—degenerative disc disease	0.000604	0.000604	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—BMP2—degenerative disc disease	0.000601	0.000601	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—MMP3—degenerative disc disease	0.000591	0.000591	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—BMP2—degenerative disc disease	0.000568	0.000568	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—COL9A2—degenerative disc disease	0.000564	0.000564	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—CHST3—degenerative disc disease	0.00055	0.00055	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—COL9A2—degenerative disc disease	0.000503	0.000503	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—CHST3—degenerative disc disease	0.000491	0.000491	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—BMP2—degenerative disc disease	0.000488	0.000488	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—BMP2—degenerative disc disease	0.000484	0.000484	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—CHST3—degenerative disc disease	0.000479	0.000479	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—BMP2—degenerative disc disease	0.000448	0.000448	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—CHST3—degenerative disc disease	0.000448	0.000448	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—BMP2—degenerative disc disease	0.00044	0.00044	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—BMP2—degenerative disc disease	0.000418	0.000418	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—BMP2—degenerative disc disease	0.000417	0.000417	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—MMP3—degenerative disc disease	0.000416	0.000416	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—MMP3—degenerative disc disease	0.000393	0.000393	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—MMP3—degenerative disc disease	0.000393	0.000393	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—BMP2—degenerative disc disease	0.000375	0.000375	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—MMP3—degenerative disc disease	0.000338	0.000338	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—MMP3—degenerative disc disease	0.000335	0.000335	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—BMP2—degenerative disc disease	0.000335	0.000335	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—MMP3—degenerative disc disease	0.000311	0.000311	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—MMP3—degenerative disc disease	0.000305	0.000305	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CHST3—degenerative disc disease	0.000295	0.000295	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—MMP3—degenerative disc disease	0.00029	0.00029	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—MMP3—degenerative disc disease	0.000289	0.000289	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—MMP3—degenerative disc disease	0.00026	0.00026	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—MMP3—degenerative disc disease	0.000232	0.000232	CbGpPWpGaD
